Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
05/2002
05/16/2002US20020058242 Generation of a chemical library on compac disk; obtain disc, fuse library to surface of disc with laser, remove subtrate
05/16/2002US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism
05/16/2002US20020057432 Multipass cavity for illumination and excitation of moving objects
05/16/2002US20020056640 Method for electrophoresis in polycarbonate electrophoretic devices
05/16/2002CA2428055A1 Process for the preparation of latent antithrombin iii
05/15/2002EP1204853A1 Inorganic permeation layer for micro-electric device
05/15/2002EP1204675A1 Streptogramin derivatives, production thereof and compositions containing the same
05/15/2002EP1204467A1 Methods and apparatus for performing array microcrystallizations
05/15/2002EP0900285A4 Technique for representing combinatorial chemistry libraries resulting from selective combination of synthons
05/14/2002US6387877 Removal lipopolysaccharides from glycoproteins; antiinflammatory agents
05/14/2002US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor
05/14/2002US6387623 Screening of drugs from chemical combinatorial libraries employing transponders
05/14/2002US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells
05/14/2002CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation
05/14/2002CA2032499C Polypeptide derivatives
05/10/2002WO2002037094A2 Gel for electrophoresis
05/10/2002WO2002037093A2 Gel trap for electrophoresis
05/10/2002WO2002036804A2 Method for detecting hematopoietic stem cells
05/10/2002WO2002036615A2 Methods for producing and improving therapeutic potency of binding polypeptides
05/10/2002WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
05/10/2002WO2002036142A2 Compositions for inhibiting grb7
05/10/2002WO2001094421A3 Method for electrophoretically separating membrane proteins
05/10/2002WO2001090304A3 Nucleic acids, proteins, and antibodies
05/10/2002WO2001077145A3 Integrin binding peptide derivatives
05/10/2002WO2001046213A3 Compound comprising a peptide moiety and an organo-silane moiety.
05/10/2002CA2427858A1 Compositions for inhibiting grb7
05/10/2002CA2427659A1 Methods for producing and improving therapeutic potency of binding polypeptides
05/10/2002CA2427022A1 Gel trap for electrophoresis
05/10/2002CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
05/09/2002US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
05/09/2002US20020055536 System and method for structure-based drug design that includes accurate prediction of binding free energy
05/09/2002US20020055169 Method for expression of heterologous proteins in yeast
05/09/2002US20020055136 Soluble recombinant alpha beta adhesion receptor
05/09/2002US20020055133 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
05/09/2002US20020054916 Comprising ceruloplasmin and a serum-derived composition (SDF) having a low molecular weight, electrically charged at acidic pH and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells
05/09/2002US20020054871 Treating a host suffering from hyperlipidemia resulting from elevated levels of at least one of very low density lipoproteins and triglycerides and effective amount of an agent that reduces the level of active apolipoprotein E
05/08/2002EP1203958A2 High-throughput screening method
05/08/2002EP1203774A1 Process for removing protein aggregates and virus from a protein solution
05/08/2002EP1203080A2 Isolation of biomolecules
05/08/2002EP1203012A2 Refolding of membrane proteins using two different detergents
05/08/2002EP1202798A1 Use of a composite polymer-coated sorbent for separation, purification, desalting and concentration of biopolymers
05/08/2002EP0789783B1 Antigen binding peptides (abtides) from peptide libraries
05/08/2002CN1348462A Novel LHRH-antagonists with improved solubility characteristics
05/07/2002US6384210 Injet print head having piezoelectric pump; head contains solvent having a boiling point above 150 degrees celsius, high surface tension and a specific viscosity; solvent does not have hydroxyl groups
05/07/2002US6384195 Produced by partitioning method; therapeutics
05/07/2002US6383487 Antitumor
05/07/2002US6383380 Chromatography resin
05/07/2002CA1341357C Platelet-specific chimeric immunoglobulin
05/02/2002WO2002035241A2 High throughput screening for protein formulations
05/02/2002WO2002034915A2 Preferred segments of neural thread protein and methods of using the same
05/02/2002WO2002034885A1 Sericin-containing material, process for producing the same and method of using the same
05/02/2002WO2002034876A2 Protein data analysis
05/02/2002WO2002034787A1 Method of producing human serum albumin involving heating step
05/02/2002WO2002034786A1 Method of eliminating human serum albumin polymers
05/02/2002WO2002034783A2 Transmembrane proteins
05/02/2002WO2002034764A1 A process of producing polyphenolic adhesive proteins and proteins produced in accordance with the process
05/02/2002WO2002034237A1 Active agent delivery systems and methods for protecting and administering active agents
05/02/2002WO2001098473A3 Method for isolating and purifying a protein and resulting protein
05/02/2002WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides
05/02/2002WO2001092311A3 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus
05/02/2002WO2001083770A3 Lipolytic enzyme variant
05/02/2002WO2001079342A3 Cross-linked collagen matrices and methods for their preparation
05/02/2002WO2001058924A3 Novel resin materials and their use for recovering proteins or peptides
05/02/2002WO2001016810A3 A computer-based method for macromolecular engineering and design
05/02/2002US20020052422 Oral drug delivery compositions and methods
05/02/2002US20020052314 Additional smooth muscle relaxant and platelet inhibitory capabilities.
05/02/2002US20020052026 Expressing preferential polypeptides in culture; obtain prokaryotic cells, culture, recover preferential polypeptide
05/02/2002US20020052014 Peptide for use in detection of methylated proteins
05/02/2002US20020051996 Modular protein libraries and methods of preparation
05/02/2002US20020051788 For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines
05/02/2002US20020051070 System and method for high numeric aperture imaging systems
05/02/2002EP1200833A1 Difference detection methods using matched multiple dyes
05/02/2002EP1200577A2 In vitro selection and optional identification of polypeptides using solid support carriers
05/02/2002EP1200471A1 Method for purifying granulocyte colony stimulating factor
05/02/2002EP1200468A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF i STAPHYLOCOCCUS AUREUS /i ELONGATION FACTOR P
05/02/2002EP1200461A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs
05/02/2002EP1200179A2 Charged filtration membranes and uses therefor
05/02/2002CA2427085A1 Transmembrane proteins
05/02/2002CA2427070A1 Preferred segments of neural thread protein and methods of using the same
05/02/2002CA2422899A1 Protein data analysis
05/02/2002CA2420590A1 Active agent delivery systems and methods for protecting and administering active agents
05/01/2002CN1347460A Monolayer and electrode for detecting label-bearing target and method of use thereof
04/2002
04/30/2002USRE37686 Biosynthesis of polypeptides
04/30/2002US6380365 Temperature dependent ligand facilitated purification of proteins
04/30/2002US6380358 Guanidinylation reagents
04/30/2002US6380355 Process for obtaining insulin precursors having correctly bonded cystine bridges
04/30/2002US6379903 Purification of recombinant proteins fused to multiple epitopes
04/30/2002US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis
04/30/2002US6379897 Methods for gene expression monitoring on electronic microarrays
04/30/2002US6379895 Photolithographic and other means for manufacturing arrays
04/30/2002US6379678 Culture product; antiallergens
04/30/2002US6379550 Chromatography
04/30/2002CA2128784C Large, latent complexes of tgf-beta2 and tgf-beta3
04/30/2002CA2093819C Platelet adhesion inhibitor
04/30/2002CA2020247C Antibodies reactive with human carcinomas
04/25/2002WO2002033065A2 Method for producing proteins by electroporation
04/25/2002WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
04/25/2002WO2002032537A2 Improved method of expanded bed chromatography
04/25/2002WO2002032445A2 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof
04/25/2002WO2001060840A3 Complementation assay assessing protein solubility and folding